Skip to main content

Table 2 Mean (SD) CGI-S and CGI-I scores for prior AMPH subgroup and overall efficacy population

From: Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study

Variable

Mean (SD) CGI scores

Prior AMPH subgroup

Overall efficacy population

Placebo (n = 2)

LDX (n = 39)

Placebo (n = 62)

LDX (n = 352)

CGI-S (Baseline)

4.5 (0.71)

4.9 (0.76)

4.7 (0.73)

4.8 (0.65)

CGI-I (Endpoint)

2.5 (0.71)

2.4 (1.11)

3.2 (1.19)

2.4 (1.07)